Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.40 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.40 |
| ▸ | TAS1R2 | Q8TE23 | 3/20 | 0.40 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.36 |
| ▸ | KDM4B | O94953 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.36 |
| ▸ | UGT2B17 | O75795 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.32 |
| ▸ | EBP | Q15125 | 1/20 | 0.32 |
| ▸ | DHCR7 | Q9UBM7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26556079 | 0.79 | ROCK2 (0.37) | TAS1R3TAS1R1TAS1R2PSMB5ROCK2 | |
| SCHEMBL19208899 | 0.79 | ROCK2 (0.38) | NPSR1GAAMEN1ALDH1A1TSHR | |
| SCHEMBL16694148 | 0.78 | ROCK2 (0.40) | TAS1R3TAS1R1TAS1R2PSMB5NR1I2 | |
| SCHEMBL29528470 | 0.76 | ROCK2 (0.37) | TAS1R3TAS1R1TAS1R2NR1I2KDM4B | |
| SCHEMBL17529736 | 0.75 | TP53 (0.37) | GAAMEN1ALDH1A1TSHRKMT2A | |
| SCHEMBL11954829 | 0.73 | HTT (0.38) | GAAMEN1ALDH1A1TSHRKMT2A | |
| SCHEMBL21348992 | 0.73 | ROCK2 (0.38) | PSMB5NPSR1GAAMEN1ALDH1A1 | |
| SCHEMBL27948023 | 0.72 | ROCK2 (0.39) | TAS1R3TAS1R1TAS1R2NR1I2KDM4B | |
| SCHEMBL19058034 | 0.71 | ROCK2 (0.34) | TAS1R3TAS1R1TAS1R2PSMB5ROCK2 | |
| SCHEMBL11761013 | 0.71 | HRH3 (0.39) | TAS1R3TAS1R1TAS1R2PSMB5NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019016115-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED ARYL KETONES | BASF Agro B.V. (NL) | 2019-01-24 | — | — | WO | claimed |
| CN-111406059-B | Europium complexes | 东曹株式会社 | 2023-04-18 | — | — | CN | disclosed |
| US-10844073-B2 | Palladium-mediated ketolization | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2020-11-24 | — | — | US | disclosed |
| WO-2020152200-A1 | PROCESS FOR PREPARATION OF HETEROARYLKETONES | BASF SE (DE) | 2020-07-30 | — | — | WO | disclosed |
| US-10392400-B2 | Palladium-mediated ketolization | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-08-27 | — | — | US | disclosed |
| WO-2019016115-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED ARYL KETONES | BASF Agro B.V. (NL) | 2019-01-24 | — | — | WO | disclosed |
| US-20180244865-A1 | INCREASED EFFICIENCY DESULFURIZATION REAGENTS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2018-08-30 | — | — | US | disclosed |
| EP-3341432-A1 | INCREASED EFFICIENCY DESULFURIZATION REAGENTS | ARLANXEO Deutschland GmbH (DE) | 2018-07-04 | — | — | EP | disclosed |
| US-20180155361-A1 | PALLADIUM-MEDIATED KETOLIZATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2018-06-07 | — | — | US | disclosed |
| EP-2853523-B1 | Process for producing fluorine-containing biaryl compound | DAIKIN IND LTD (JP) | 2018-05-30 | — | — | EP | disclosed |
| US-20130261305-A1 | PROCESS OF MAKING GYRASE AND TOPOISOMERASE INHIBITORS | SPERO THERAPEUTICS, INC. | 2013-10-03 | — | — | US | disclosed |
| EP-2610248-A1 | METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE BY MEANS OF COUPLING METHOD USING A PALLADIUM COMPOUND | Teijin Pharma Limited (JP) | 2013-07-03 | — | — | EP | disclosed |
| US-8471014-B2 | Process of making gyrase and topoisomerase IV inhibitors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-06-25 | — | — | US | disclosed |
| US-20130158272-A1 | METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE BY MEANS OF COUPLING METHOD USING PALLADIUM COMPOUND | TEIJIN PHARMA LIMITED (JP) | 2013-06-20 | — | — | US | disclosed |
| WO-2013032035-A1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-03-07 | — | — | WO | disclosed |
| WO-2013032035-A1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-03-07 | — | — | WO | disclosed |
| US-20120184742-A1 | PROCESS OF MAKING GYRASE AND TOPOISOMERASE IV INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-07-19 | — | — | US | disclosed |
| WO-2012097274-A1 | PROCESS OF MAKING GYRASE AND TOPOISOMERASE IV INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATION (US) | 2012-07-19 | — | — | WO | disclosed |
| EP-2404908-A1 | PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST | Teijin Pharma Limited (JP) | 2012-01-11 | — | — | EP | disclosed |
| US-20110313169-A1 | PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST | TEIJIN PHARMA LIMITED (JP) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313169-A1 | PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST | XDH, PAH, HPRT1 | TAS1R3 3433/4885TAS1R1 3431/4885TAS1R2 3642/4885 |
| US-10844073-B2 | Palladium-mediated ketolization | ERLIN1, ERLIN2, PDK1 | TAS1R3 4518/4885TAS1R1 4448/4885TAS1R2 4609/4885 |
| US-20120184742-A1 | PROCESS OF MAKING GYRASE AND TOPOISOMERASE IV INHIBITORS | TOP1, TOP2A, TOP2B | TAS1R3 3664/4885TAS1R1 3881/4885TAS1R2 4204/4885 |
| US-20130158272-A1 | METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE BY MEANS OF COUPLING METHOD USING PALLADIUM COMPOUND | XDH, AOC1, PAH | TAS1R3 4399/4885TAS1R1 4308/4885TAS1R2 4593/4885 |
| US-20180155361-A1 | PALLADIUM-MEDIATED KETOLIZATION | ERLIN1, ERLIN2, PDK1 | TAS1R3 4518/4885TAS1R1 4448/4885TAS1R2 4609/4885 |
| US-10392400-B2 | Palladium-mediated ketolization | ERLIN1, ERLIN2, PDK1 | TAS1R3 4518/4885TAS1R1 4448/4885TAS1R2 4609/4885 |
| US-20130261305-A1 | PROCESS OF MAKING GYRASE AND TOPOISOMERASE INHIBITORS | TOP1, TOP2A, TOP2B | TAS1R3 3434/4885TAS1R1 3669/4885TAS1R2 4076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.